Introduction ADVERTISEMENT Peptides have become a focal point in research due to their intricate interactions with metabolic ...

Investigating ECM changes in the hypothalamus reveals mechanisms behind insulin resistance, offering insights into obesity ...

Modern lifestyles characterized by irregular routines, high-fat and high-salt diets, and a preference for refined foods, ...

Kim, J. and Sadiora, K. (2024) Systematic Analysis of Post-Translational Modifications for Increased Longevity of ...

In this article, we take a look at six biotech companies focused on bringing drugs to treat obesity to the market.

In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker ...

Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...

They taste sweet because they are recognized by the sweetness receptors on your tongue ... Only a minority of artificial sweeteners have a structure that your body can break down into calories.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $34.0, a high ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.